TCL Archive Cooperative Group Competing Renewals May Be Funded Only at 70-80% Of Amounts Recommended By CCIRC January 2, 1981
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
